Choosing a contract manufacturer is one of the few decisions a supplement or herbal brand cannot easily undo. Once your product is registered, labelled and on shelves with one partner, moving it to another means new validation batches, new stability data and, in some markets, new filings. It is worth spending the time up front.
This checklist is written for brand owners, sourcing managers and quality leads who are evaluating a manufacturer for botanical, Ayurvedic or nutraceutical products. It focuses on what to ask, what evidence to request and what a good answer looks like. It is general guidance, not legal or regulatory advice; your importer of record and regulatory adviser should confirm what applies in your market.
1. Start with responsibility: what stays with you
Outsourcing manufacturing does not outsource accountability. In the United States, the dietary supplement good manufacturing practice rule (21 CFR Part 111) applies to anyone who manufactures, packages, labels or holds a dietary supplement. FDA's Small Entity Compliance Guide gives the example of a distributor that has a manufacturer make a supplement sold under the distributor's own label: the distributor still "has an obligation to know what and how manufacturing activities are performed" so it can decide whether the product meets its specifications and whether to release it.
Other markets frame this differently, but the principle is similar: the brand owner or the person placing the product on the market answers for it. So the question is not only "is this manufacturer good?" but "will this manufacturer give me what I need to discharge my own responsibilities?"
2. Certificates: verify, don't just collect
Ask for the manufacturer's current good manufacturing practice certificate and any other certifications it relies on. For herbal products, the reference standard most buyers recognise is the World Health Organization's guidance on good manufacturing practices for herbal medicines.
For each certificate, check:
- Validity dates. Certificates expire. An expired certificate is not evidence of current compliance.
- Scope. Which site, which product categories and which dosage forms are covered? A certificate for tablets at one site says nothing about syrups at another.
- Issuer. Who issued it, a regulator, a state authority or a private certification body? Can you verify it with the issuer?
- Inspection history. Ask when the site was last inspected and whether any observations remain open.
3. The audit: what to look at
An on-site audit is still the best evidence. If travel is not practical, a structured remote audit with a live video walk-through and document review is a reasonable first step, followed by an on-site visit before commercial launch.
Focus on systems, not décor:
- Raw material control. How are botanical raw materials received, quarantined, sampled, tested and released? Is there a separate area for rejected material?
- Identity testing. Under US rules, a manufacturer must conduct at least one appropriate test or examination to verify the identity of every dietary ingredient before use (21 CFR 111.75). For botanicals, ask which methods they use (for example macroscopy, microscopy or chromatographic fingerprinting such as HPTLC) and see the records.
- Supplier qualification. How does the manufacturer decide which herb and extract suppliers to trust? Do they periodically confirm supplier test results independently?
- Batch records. Ask to see a completed (redacted) batch manufacturing record. It should show who did what, when, with which materials and equipment, and how deviations were handled.
- Cleaning and cross-contamination. How is equipment cleaned between products, and how is cleaning verified?
- Complaints, deviations and recalls. Ask for the procedure and an anonymised example of how a recent deviation was investigated and closed.
- Change control. How will they notify you before changing a supplier, a process or a site?
4. Certificates of analysis: what a useful COA contains
A certificate of analysis (COA) should be a record of real tests on your batch, not a restatement of the specification. US rules set out what a supplier COA must include if a manufacturer relies on it for a component: a description of the test methods used, the limits, and the actual results (21 CFR 111.75(a)(2)). That is a sensible standard to apply to finished-product COAs too.
For a herbal or nutraceutical finished product, expect the COA to cover, as relevant to the product:
- Description and identity
- Assay of declared ingredients or marker compounds, with the method named
- Physical tests for the dosage form (for example average weight, disintegration, moisture or pH)
- Microbiological limits
- Heavy metals, and where relevant pesticide residues, aflatoxins and residual solvents
- Batch number, manufacturing and expiry or retest dates, and a signature from quality
Ask whether testing is done in-house, by an external laboratory, or both, and whether external laboratories are accredited. WHO's guidelines on assessing herbal quality with reference to contaminants and residues and quality control methods for herbal materials are useful references for what to test.
5. Specifications: agree them in writing before the first batch
Most disputes between brands and manufacturers come down to an unwritten specification. Before development starts, agree in writing:
- The exact identity of each botanical (Latin binomial and plant part), and whether it is a powder or an extract (see our guide on standardised extracts vs raw herb powders)
- Label claim per serving and the acceptable range
- Contaminant limits that match your destination market, not only the country of manufacture
- Packaging components and their specifications
- Which tests appear on every COA, and which are periodic
6. Stability and shelf life
Ask how the manufacturer supports the shelf life printed on your label. For US dietary supplements, FDA does not require an expiration date, but its compliance guide states you should have data to support any expiration, shelf or "best if used by" date you put on the label (Small Entity Compliance Guide).
Many manufacturers borrow the design of pharmaceutical stability studies. WHO's stability testing guideline sets storage conditions by climatic zone, including 30 °C / 75% relative humidity for hot and very humid regions. If your product will be sold or stored in a hot, humid climate, ask whether stability has been or will be run under conditions that reflect it, and in the final pack.
Good questions:
- Is there real-time data, or only accelerated data with a projected shelf life?
- Which parameters are tracked (assay or markers, moisture, appearance, microbiology)?
- Will stability be repeated if the formula, supplier or pack changes?
7. Technology transfer: moving an existing product
If you already have a product made elsewhere, plan the transfer like a project. Provide, or ask your previous manufacturer for:
- Full formula with grades and suppliers of each ingredient
- Raw material and finished product specifications and test methods
- The master manufacturing process, including critical steps and in-process controls
- Historical COAs and any stability data
- Packaging specifications and artwork
Expect the new manufacturer to make trial or validation batches and compare them against your historical data before commercial supply. Ask who owns the formula and the data, and put it in the contract.
8. MOQ, lead times and capacity
Minimum order quantity (MOQ) is driven by batch size, equipment, packaging component minimums and set-up costs. A low MOQ is useful for launch, but ask how pricing changes as you scale and whether the same line will make larger volumes. Confirm lead times for samples, first commercial batch and repeat orders, and which inputs (often printed packaging and imported ingredients) drive those lead times.
9. Put it in a quality agreement
A quality agreement defines who does what: specifications, testing, release, change control, complaints, recalls and audit rights. FDA's guidance on quality agreements for contract manufacturing of drugs is written for medicines, but its structure is a practical model for supplements and herbal products too. A manufacturer that is reluctant to sign one is telling you something.
10. Red flags
- Certificates that are expired, cover a different site, or cannot be verified with the issuer
- COAs that list only "complies" with no methods or actual results
- No written answer on how shelf life is supported
- Reluctance to allow an audit or to share a redacted batch record
- Vague answers on where raw materials come from
- Promises of regulatory approval in your market. A manufacturer can support your filing; it cannot guarantee the regulator's decision.
The checklist in one place
| Area | What to ask for |
|---|---|
| Responsibility | A clear split of duties in a quality agreement |
| Certificates | Current GMP certificate; validity, scope and issuer verified |
| Audit | On-site or structured remote audit; raw material, batch record and cleaning review |
| Identity | Identity test method for each botanical, with records |
| COAs | Methods, limits and actual results on every batch |
| Specifications | Written, market-appropriate limits agreed before development |
| Stability | Data that supports the labelled shelf life, in the final pack |
| Tech transfer | Formula, specs, process, historical data; trial batches compared |
| Commercials | MOQ, lead times, scale-up pricing, IP ownership |
How we approach this at Amulya Labs
We manufacture Ayurvedic, nutraceutical and personal care products for brands, business to business only, in a WHO-GMP certified facility and with more than 40 years of manufacturing heritage behind us. Every order ships with COAs, MSDS and the export documentation buyers need, our minimum order is 5,000 units, and Amulya Research Centre can run in vitro, animal, human and dermatological studies when a product needs evidence behind it. We would rather answer the questions in this checklist before you place an order than after.
This guide is general information for B2B buyers, not legal or regulatory advice. Requirements change; check current rules with your regulatory adviser.